Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

32.90p
   
  • Change Today:
    -0.60p
  • 52 Week High: 56.40
  • 52 Week Low: 29.35
  • Currency: UK Pounds
  • Shares Issued: 540.40m
  • Volume: 768,268
  • Market Cap: £177.79m
  • RiskGrade: 119

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
65.56% below the market average65.56% below the market average65.56% below the market average65.56% below the market average65.56% below the market average
80% below the sector average80% below the sector average80% below the sector average80% below the sector average80% below the sector average
1yr Revenue Growth
24.51% below the market average24.51% below the market average24.51% below the market average24.51% below the market average24.51% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
39.78% above the market average39.78% above the market average39.78% above the market average39.78% above the market average39.78% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
1yr DPS Growth
8.97% below the market average8.97% below the market average8.97% below the market average8.97% below the market average8.97% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
34.81% below the market average34.81% below the market average34.81% below the market average34.81% below the market average34.81% below the market average
79.31% below the sector average79.31% below the sector average79.31% below the sector average79.31% below the sector average79.31% below the sector average
Price Book Ratio
59.40% above the market average59.40% above the market average59.40% above the market average59.40% above the market average59.40% above the market average
68.18% above the sector average68.18% above the sector average68.18% above the sector average68.18% above the sector average68.18% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
37.55% below the market average37.55% below the market average37.55% below the market average37.55% below the market average37.55% below the market average
13.21% below the sector average13.21% below the sector average13.21% below the sector average13.21% below the sector average13.21% below the sector average
Price Chg 3m
56.8% below the market average56.8% below the market average56.8% below the market average56.8% below the market average56.8% below the market average
13.21% below the sector average13.21% below the sector average13.21% below the sector average13.21% below the sector average13.21% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
13.33% above the market average13.33% above the market average13.33% above the market average13.33% above the market average13.33% above the market average
6.12% above the sector average6.12% above the sector average6.12% above the sector average6.12% above the sector average6.12% above the sector average
Momentum 20
21.07% below the market average21.07% below the market average21.07% below the market average21.07% below the market average21.07% below the market average
38.78% below the sector average38.78% below the sector average38.78% below the sector average38.78% below the sector average38.78% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
4.55% below the market average4.55% below the market average4.55% below the market average4.55% below the market average4.55% below the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average
ROCE
22.52% above the market average22.52% above the market average22.52% above the market average22.52% above the market average22.52% above the market average
7.69% below the sector average7.69% below the sector average7.69% below the sector average7.69% below the sector average7.69% below the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
10.18% above the market average10.18% above the market average10.18% above the market average10.18% above the market average10.18% above the market average
68.00% above the sector average68.00% above the sector average68.00% above the sector average68.00% above the sector average68.00% above the sector average
Forecast EPS
62.38% below the market average62.38% below the market average62.38% below the market average62.38% below the market average62.38% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
37.49% above the market average37.49% above the market average37.49% above the market average37.49% above the market average37.49% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average
Operating Profit Loss
30.79% above the market average30.79% above the market average30.79% above the market average30.79% above the market average30.79% above the market average
76.00% above the sector average76.00% above the sector average76.00% above the sector average76.00% above the sector average76.00% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
41.68% above the market average41.68% above the market average41.68% above the market average41.68% above the market average41.68% above the market average
58.33% above the sector average58.33% above the sector average58.33% above the sector average58.33% above the sector average58.33% above the sector average
Cash
42.02% above the market average42.02% above the market average42.02% above the market average42.02% above the market average42.02% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
59.61% below the market average59.61% below the market average59.61% below the market average59.61% below the market average59.61% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average
Buys 1y
2.59% below the market average2.59% below the market average2.59% below the market average2.59% below the market average2.59% below the market average
13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
48.94% below the market average48.94% below the market average48.94% below the market average48.94% below the market average48.94% below the market average
52.94% below the sector average52.94% below the sector average52.94% below the sector average52.94% below the sector average52.94% below the sector average
Brokers Percent Neutral
39.06% above the market average39.06% above the market average39.06% above the market average39.06% above the market average39.06% above the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 32.90p
Change Today -0.60p
% Change -1.79 %
52 Week High 56.40
52 Week Low 29.35
Volume 768,268
Shares Issued 540.40m
Market Cap £177.79m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.47% above the market average94.47% above the market average94.47% above the market average94.47% above the market average94.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
74.91% below the market average74.91% below the market average74.91% below the market average74.91% below the market average74.91% below the market average
16.98% below the sector average16.98% below the sector average16.98% below the sector average16.98% below the sector average16.98% below the sector average
Income
35.94% above the market average35.94% above the market average35.94% above the market average35.94% above the market average35.94% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
89.14% below the market average89.14% below the market average89.14% below the market average89.14% below the market average89.14% below the market average
88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 17-Jun-2024

Time Volume / Share Price
16:27 137 @ 32.90p
16:21 1,000 @ 33.05p
16:21 242 @ 32.90p
16:11 22,500 @ 32.92p
16:05 720 @ 32.92p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Camillo Pane

Top of Page